Viking Therapeutics, Inc. (VKTX)

$ 26.07
   
  • Change Today:
    $0.41
  • 52 Week High: $78.03
  • 52 Week Low: $21.28
  • Currency: US Dollars
  • Shares Issued: 72.03m
  • Volume: 8,224,475
  • Market Cap: $1,877.76m
  • RiskGrade: 326

Latest ShareCast News

Viking Therapeutics soars 120% following positive results from VK2809

By Iain Gilbert

Date: Tuesday 18 Sep 2018

(Sharecast News) - Viking Therapeutics soared as much as 120% in early trading after the firm revealed a positive set of results from a mid-stage trial of its non-alcoholic fatty liver disease treatment.

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

VKTX Market Data

Currency US Dollars
Share Price $ 26.07
Change Today $ 0.41
% Change 1.60 %
52 Week High $78.03
52 Week Low $21.28
Volume 8,224,475
Shares Issued 72.03m
Market Cap $1,877.76m
RiskGrade 326

What The Brokers Say

Strong Buy 7
Buy 10
Neutral 2
Sell 0
Strong Sell 0
Total 19
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 22-Aug-2025

Time Volume / Share Price
14:49 100 @ $26.07
14:49 150 @ $26.06
14:49 314 @ $26.06
14:49 250 @ $26.08
14:49 100 @ $26.06

Top of Page